During the past decade, Ospedale Cattinara; Amb Studio Sclerosi Multipla, Clinica Neurlogica conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale Cattinara; Amb Studio Sclerosi Multipla, Clinica Neurlogica" are "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Progressive Multiple Sclerosis (PMS)" (1 trials). Many other conditions were trialed in "Ospedale Cattinara; Amb Studio Sclerosi Multipla, Clinica Neurlogica" in a lesser frequency.

Most popular intervention types in "Ospedale Cattinara; Amb Studio Sclerosi Multipla, Clinica Neurlogica" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Cattinara; Amb Studio Sclerosi Multipla, Clinica Neurlogica" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Cattinara; Amb Studio Sclerosi Multipla, Clinica Neurlogica". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ospedale Cattinara; Amb Studio Sclerosi Multipla, Clinica Neurlogica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Cattinara; Amb Studio Sclerosi Multipla, Clinica Neurlogica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".